Microsoft is still undervalued, this investor says

Goodreid Investment Counsel president and CEO Gordon Reid says Microsoft (Microsoft Stock Quote, Chart, News, Analysts, Financials NASDAQ:MSFT) remains undervalued despite investor concerns that its AI position has weakened.

Speaking on BNN Bloomberg’s Market Call on June 15, Reid said concerns about Microsoft’s AI strategy are legitimate, given its close relationship with OpenAI and rising competition from Anthropic and Google’s Gemini.

But Reid said Microsoft’s recent renegotiation of its OpenAI agreement should give the company more flexibility.

“What has happened in the last few weeks is that Microsoft has renegotiated their deal with OpenAI to give them more latitude, to give them more opportunity to explore other avenues,” Reid said. “We think that’s going to open up big things for Microsoft.”

Reid said Azure, Microsoft’s cloud platform, is growing at more than 40% and remains second only to Amazon Web Services.

He also said Microsoft’s broad software footprint gives it a strong base for AI applications.

“The software offerings that Microsoft has, whether it’s through Windows or you name it, is a perfect launching pad for an AI application,” Reid said.

Reid said the stock remains attractive at about 30% below its highs.

 

-30-

Tagged with: msft
Rod Weatherbie

Rod Weatherbie is a journalist based in Prince Edward Island. Since 2004, he has written extensively about the Canadian property and casualty insurance landscape. He was also a founder and contributing editor for a Toronto-based arts website and a PEI-based food magazine. His fiction and poetry have been featured in The Fiddlehead, The Antigonish Review, and Juniper.

Recent Posts

What’s going on with Canada’s job losses?

RBC senior economist Claire Fan says Canada’s September job losses were concentrated among younger workers and should not be overread.… [Read More]

2 hours ago

This biotech stock has a massive upside, Roth says

Roth Capital Partners analyst Adam Walsh says a third controlled celiac disease dataset supporting IL-15 blockade increases the potential value… [Read More]

2 hours ago

Red-hot Firan Technology wins another price target raise

Beacon Securities analyst Russell Stanley raised his target on Firan Technology Group (Firan Technology Group Stock Quote, Chart, News, Analysts,… [Read More]

17 hours ago

Buy this Canadian pot stock, Research Capital says

Research Capital Corporation analyst Greg McLeish maintained his “Buy” rating and $3.50 target on Cannara Biotech (Cannara Biotech Stock Quote,… [Read More]

1 day ago

Amazon is still a “reasonably cheap” stock, this investor says

Propellus Wealth Partners portfolio manager and senior wealth advisor Mike Vinokur says Amazon (Amazon.com Stock Quote, Chart, News, Analysts, Financials… [Read More]

1 day ago

Is AmeriTrust Financial Technologies undervalued?

Clarus Securities analyst Noel Atkinson reiterated his “Speculative Buy” rating and $0.30 target on AmeriTrust Financial Technologies (AmeriTrust Financial Technologies… [Read More]

1 day ago